Author:
Hegerova Livia T.,Leal Alexis D.,Grendahl Darryl C.,Seisler Drew K.,Sorgatz Kristine M.,Anderson Kari J.,Hilger Crystal R.,Loprinzi Charles L.
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Celio L, Ricchini F, De Braud F (2013) Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting. Patient Prefer Adherence 7:391–400
2. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358(23):2482–2494
3. Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American society of clinical oncology clinical practice guideline update. J Clin Oncol 29(31):4189–4198
4. Roila F, Herrstedt J, Aapro M et al (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232–243
5. National Comprehensive Cancer Network: clinical practice guidelines in oncology: antiemesis, version 1. 2013. 2013. http://www.nccn.org/professional/physician_gls/PDF/antiemesis.pdf . Accessed June 24th, 2013.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献